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Calcitonin gene-related peptide (CGRP) is a neuroactive peptide that is thought to
play a role at efferent synapses in hair cell organs including the cochlea, lateral
line, and semicircular canal. The deletion of CGRP in transgenic mice is associated
with a significant reduction in suprathreshold cochlear nerve activity and vestibulo–
ocular reflex (VOR) gain efficacy when compared to littermate controls. Here we asked
whether the loss of CGRP also influences otolithic end organ function and contributes
to balance impairments. Immunostaining for CGRP was absent in the otolithic end
organs of αCGRP null (−/−) mice while choline acetyltransferase (ChAT) immunolabeling
appeared unchanged suggesting the overall gross development of efferent innervation
in otolithic organs was unaltered. Otolithic function was assessed by quantifying the
thresholds, suprathreshold amplitudes, and latencies of vestibular sensory-evoked
potentials (VsEPs) while general balance function was assessed using a modified rotarod
assay. The loss of αCGRP in null (−/−) mice was associated with: (1) shorter VsEP
latencies without a concomitant change in amplitude or thresholds, and (2) deficits in the
rotarod balance assay. Our findings show that CGRP loss results in faster otolith afferent
activation timing, suggesting that the CGRP component of the efferent vestibular system
(EVS) also plays a role in otolithic organ dynamics, which when coupled with reduced
VOR gain efficacy, impairs balance.
Keywords: CGRP, otolith, vestibular efferent, sensory coding, mouse, VsEP, rotarod, balance
INTRODUCTION
Calcitonin gene-related peptide (CGRP) is a 37 amino-acid neuroactive peptide commonly
found in efferent neurons innervating hair cell organs including the cochlea, lateral line,
semicircular canals, and otolithic end organs (Adams et al., 1987; Wackym et al., 1993; Maison
et al., 2003a,b; Dickerson et al., 2016). In mammals (Figures 1A,B), the efferent vestibular
system (EVS) begins as hundreds of parent neurons in the dorsal brainstem, which project
bilaterally and then branch extensively to make numerous synapses on type II hair cells and
afferent terminals including calyces surrounding type I hair cells (Lysakowski et al., 1995;
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Holt et al., 2006; Lysakowski and Goldberg, 2008). At these
synapses, CGRP is commonly colocalized in presynaptic
efferent varicosities with choline acetyltransferase (ChAT), the
enzyme that catalyzes the synthesis of acetylcholine (ACh),
the predominant EVS transmitter (Goldberg, 2000). Electrical
stimulation of the EVS produces excitatory afferent responses
comprised of fast and/or slow components which are of larger
amplitude in irregularly-discharging afferents (Goldberg and
Fernandez, 1977; Goldberg et al., 1987; Curthoys et al., 1995).
Similar efferent-mediated effects are evoked by high-velocity
stimulation (Sadeghi et al., 2007, 2009). Recent pharmacological
evidence has demonstrated a role for alpha9-containing nicotinic
ACh receptors (α9 nAChRs) on type II hair cells and alpha4beta2-
containing nAChRs and muscarinic AChRs on bouton and
calyx-bearing afferents (Holt et al., 2015, 2017; Poppi et al.,
2018).
However, the widespread co-expression of CGRP at these
same cholinergic synapses suggests that it too impacts peripheral
vestibular function (Guth and Norris, 1993; Guth et al., 1998;
Holt et al., 2011). We have previously examined a transgenic
mouse line [CGRP null (−/−)] with targeted deletion of the
alpha isoform of the CGRP gene (αCGRP) where CGRP staining
was clearly absent in the semicircular canal cristae, while ChAT
immunostaining in the same tissue was comparable to cristae
from control animals. The loss of αCGRP in null (−/−) mice
was associated with a 50% decrease in vestibulo–ocular reflex
(VOR) gain efficacy (Luebke et al., 2014). While a potential
role for CGRP in semicircular canal function was identified, the
significance of CGRP for otolithic organ function was unknown.
We wondered if otolithic function in null (−/−) mice might
also be affected by the loss of CGRP. Like canal cristae, we
confirmed that CGRP staining was absent in the vestibular otolith
end organs of CGRP null (−/−) mice, while ChAT staining in
otolith end organs was comparable to wildtype mice. To access
the functional implications of CGRP loss in the otolith end
organs, we characterized the otolith-driven vestibular evoked
potentials (VsEPs). VsEP measurements are altered in mice
lacking α9 nAChRs (Morley et al., 2017), and we reasoned that
the VsEP might also provide some insight into otolithic function
in CGRP null (−/−) mice. In mice lacking CGRP, we found
significantly shorter VsEP latencies without concomitant changes
in VsEP amplitudes or thresholds. We further assessed balance
function using a modified rotarod paradigm where we found
that the performance of CGRP null (−/−) mice during testing
was impaired compared to littermate controls. Collectively, our
results suggest that the EVS neurotransmitter CGRP plays a role
in tuning otolith dynamics that when coupled with reduced VOR
gain efficacy impairs balance.
MATERIALS AND METHODS
Animals
αCGRP null (−/−) and wildtype (+/+) transgenic mouse
lines were created and characterized by the Emeson laboratory
on a pure 129SvEv background (Lu et al., 1999). These
animals were shipped to the Luebke laboratory, maintained as
heterozygotes, and genotyped using their previously described
methods. The αCGRP null (−/−) mice have a targeted deletion
of αCGRP, produced by tissue-specific alternative splicing of the
calcitonin/αCGRP gene while leaving the highly homologous
βCGRP gene intact (Lu et al., 1999). Because the absence of
αCGRP in the vasculature of CGRP (−/−) null animals was
compensated by βCGRP, there were no reported abnormalities
in heart rate or blood pressure under basal or exercise-induced
conditions, which could have been confounding issues in our
study.
αCGRP (+/−) mice were paired to generate homozygous
CGRP (−/−) and CGRP (+/+) offspring used for all mouse
studies. A total of 67 mice (both sexes) were used in these studies:
n = 8 (+/+) and n = 18 CGRP (−/−) mice for VsEP testing,
n = 3 (+/+) and n = 3 (−/−) mice for histology, and n = 20
(+/+) and n = 15 (−/−) mice were for rotarod performance. No
sex differences in VsEP responses, rotarod balance function, or
histology were found, so data were pooled across sex. Genotyped
CGRP mice were shipped to the University of Nebraska for use
in VsEP experiments. The care and use of these animals was
approved by both University of Rochester’s and University of
Nebraska’s Institutional Animal Care and Use Committees.
FIGURE 1 | (A) Efferent neurons synapse directly onto calyceal afferents innervating vestibular type I hair cells. (B) Vestibular afferents project into the brainstem and
synapse in the vestibular nuclei. Efferent cell bodies are found in the brainstem medial to the vestibular nuclei. (C) For otolith testing using vestibular evoked
potentials (VsEP), a linear jerk pulse is applied to the mouse’s head via a mechanical shaker that moves the head along the naso-occipital axis.
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Morphological/Immunohistochemical
(IHC) Studies
Six mice, three each of αCGRP (−/−) and three αCGRP
(+/+) (2M/1F) mice were anesthetized with ketamine
(80 mg/kg)/xylazine (5 mg/kg) and perfused with heparinized
PBS followed by 4% paraformaldehyde (PFA). Each animal was
subsequently decapitated and the head was postfixed in 4% PFA
overnight at 4◦C. Whole otolithic maculae were extracted from
the temporal bone and washed several times in 0.1 M phosphate
buffer (PB). Maculae were then blocked with 5% normal donkey
sera (Jackson Immunoresearch, Westgrove, PA, United States)
and 0.5% Triton X in PB, and then incubated with primary
antibodies (see below) in PB overnight. Following several washes
with PB, tissue sections were reacted with the appropriate
Alexa Fluor R©-conjugated secondary antibodies (Molecular
Probes/Invitrogen, Grand Island, NY, United States) at 1:500
in PB for 2–3 h. All tissues were then washed in PB, stained
w/DAPI (10 µg/ml, Sigma, St. Louis, MO, United States), and
mounted onto Plus Slides (Fisher Scientific) and coverslipped
with SlowFade Gold mounting media (Invitrogen).
Antibodies
Antibodies against ChAT and CGRP were used to label vestibular
efferent fibers and varicosities in mouse otolithic organs. ChAT
antibodies (Millipore, Billerica, MA, United States; AB144P
lot JC1618187, 1:100 dilution or lot NG1780580, 1:250–1:500
dilution) were generated against the human placental enzyme.
The CGRP (MU33) antibody (1:500 dilution) was generated
against the amidated carboxyl seven amino acids of rat CGRP
(Rosenblatt and Dickerson, 1997). These seven amino acids are
conserved in mouse CGRP by both alpha- and beta-isoforms.
Imaging/Quantification
Images of labeled efferent neurons in whole otolithic maculae
were captured using either an Olympus FV1000 laser scanning
confocal microscope (URMC Light Microscopy Core) with a
PLAPON 60× oil objective and sequential scanning option
or a Zeiss Axio Imager motorized upright multifluorescent
microscope fitted with an Apotome slider system (Zeiss Imaging
Systems, Oberkochen, Germany). Images and maximum
intensity projections were created and post processed using
Olympus FV1000 or Zeiss Axiovision imaging software.
Adjustments of contrast and brightness were maintained within
the linear range and Adobe Photoshop and Illustrator CS6 were
used to compile final figures.
VsEP Testing
For VsEP testing, 18 (8M/10F) αCGRP (−/−) and 8 (4M/4F)
αCGRP (+/+) mice were anesthetized with an intraperitoneal
injection of ketamine (90 mg/kg) and xylazine (10 mg/kg)
mixture, and tested using VsEP recordings methods published
previously (Mock et al., 2011). Linear acceleration pulses, 2 ms
duration, were presented to the cranium via a non-invasive
spring clip that encircled the head and secured it to a voltage-
controlled mechanical shaker as shown in Figure 1C. Stimuli
were presented along the naso-occipital axis at a rate of
17 pulses/sec. Stimulus levels ranged from +6 dB to –18 dB
re: 1.0g/ms (where 1g = 9.8 m/s2) adjusted in 3 dB steps.
Stainless steel wire was placed subcutaneously at the nuchal
crest to serve as the non-inverting electrode. Needle electrodes
were placed posterior to the left pinna and at the hip for
inverting and ground electrodes, respectively. Traditional signal
averaging was used where ongoing electroencephalographic
activity was amplified (200,000X), filtered (300 to 3000 Hz),
and digitized (100 kHz sampling rate), with 256 primary
responses averaged for each waveform. All responses were
replicated. A broadband forward masker (50 to 50,000 Hz,
94 dB SPL) was presented during VsEP measurements to
verify absence of cochlear responses (Jones and Jones, 1999).
VsEP thresholds were defined as the stimulus level midway
between the minimum level that produced a discernable
response and the maximum level where no response was
detectable. Response peak latency was defined as the time, in
milliseconds, from onset of the stimulus to the appearance of
each positive (p1, p2) and negative (n1) response peak. Peak-
to-peak amplitude (p1–n1) was measured in microvolts (µV).
Thresholds, latencies, and amplitudes were compared between
CGRP (−/−) null and CGRP (+/+) wild type controls using
multivariate analysis of variance (MANOVA) and Student’s
t-tests.
Rotarod Testing
For modified rotarod testing 15 (8M/7F) αCGRP (−/−) and
20 (10M/10F) αCGRP (+/+) were testing using a Rotomex-5
Accelerating Rotarod (Columbus Instruments) using cylindrical
dowels (69.5 mm in diameter). By using larger dowels (rat sized),
the mice were effectively unable to grasp dowels and, as such, the
rotarod becomes more of a test of balance and gait as detailed
in Tung et al. (2014, 2016) . Rotarod testing occurred in three
phases: Mice were first placed on a stationary rotarod for up
to 60 s or until falling, whichever occurred first. Latency to
fall was recorded automatically via a pressure sensitive floor
panel. A second set of training trials was repeated for each
mouse approximately 10 min after completion of the first set
of stationary testing. Here, mice were placed first on a 5-rpm
rotating dowel followed by a series of rotations that accelerated
from 5 rpm to a final speed of 44 rpm over 60 s. During this
time, mice were required to walk in a forward direction on the
rotating dowels for as long as possible. When mice were no longer
able to walk on the rotating dowels, they fell onto the landing
platform below, which triggered the end of the trial for an animal.
Training runs were repeated and measurements of time to fall
(TTF) were noted for each trial. A final set of three rotation test
trials were performed and TTF values were logged∼ 15 min after
the training runs. In this final phase, each test trial was separated
by 10 min where mice were returned to cage for food and water
and rest.
Data Analysis
Graphpad Prism software (Version 7) was used for statistical
analysis. Unless otherwise stated, analyzes were conducted using
either two-tailed Student’s t-test or ANOVA, or their non-
parametric equivalent, and significance was set at p < 0.05.
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Either Tukey or Bonferroni post hoc tests were used for multiple
comparisons. Values are reported as mean ± SD unless noted
otherwise.
RESULTS
A light-microscopic examination revealed no gross structural
abnormalities in the otolithic end organs of αCGRP (−/−)
null animals. Utricles and saccules from αCGRP (+/+) and
(−/−) animals were immunostained for CGRP and ChAT to
visualize cholinergic efferent innervation, and were visualized
using confocal microscopy. In the utricular macula of CGRP
(+/+) mice, antibodies to CGRP and ChAT strongly labeled
efferent fibers and varicosities (Figures 2a,b). There was an
extensive overlap in the distributions of staining for CGRP and
ChAT where immunoreactive varicosities positive for both ChAT
and CGRP appear as yellow and orange puncta (Figure 2c).
There were some variations in the labeling intensity for ChAT
and CGRP across the macula but no consistent patterns were
observed that might indicate differences in regional innervation.
Inspection at higher magnification revealed that most CGRP
neurons were also ChAT-positive. However, there were short
strings of fibers and variosities that appeared to primarily
express CGRP. While we cannot exclude the possibility that
these minor innervation patterns represent a distinct neuronal
population, subsequent varicosities along the same string were
immunostained for both ChAT and CGRP suggesting, instead,
that the content of individual varicosities may vary (Figure 2c).
Inspections at higher magnification, however, revealed that
most fibers and varicosities were positive for both. Whether
these represent distinct efferent neuronal groups is unclear.
Comparable immunohistochemistry in αCGRP (−/−) mice
revealed that CGRP immunoreactive fibers and varicosities were
absent from utricular epithelium (Figure 2d). When images
from CGRP and ChAT immunostaining in CGRP (−/−) mice
were merged, only ChAT+ fibers and varicosities were detected
(Figures 2e,f). Despite the loss of CGRP staining, ChAT labeling
appeared similar between CGRP (+/+) and CGRP (−/−) mice
(Figures 2b,e). Comparable observations were made in saccular
maculae (data not shown).
The VsEP is a sensitive measure to characterize the functional
status of the otolith organs (Jones and Jones, 1999, 2014;
Jones et al., 2001; Brown et al., 2017). A concise and definitive
summary of the physiological basis of the VsEP and the nature
of the vestibular neurons generating the VsEP can be found in
Jones et al. (2015).
VsEPs are compound action potentials generated when a
linear jerk pulse is applied to the mouse’s head (Figure 1C). The
responses can be recorded from the surface of the skull much like
the widely used auditory brainstem response (ABR), and like the
ABR, the VsEP contains one response peak that is generated by
the peripheral vestibular nerve (p1–n1) and two or more peaks
generated by central vestibular relays (p2 and beyond). To test the
effects that the loss of CGRP would have on otolithic function, we
recorded VsEPs in mice lacking CGRP (−/−) and control (+/+)
mice.
Robust VsEPs were obtained for both CGRP (+/+) and
CGRP (−/−) mice. Representative waveforms for CGRP (+/+)
and CGRP (−/−) mice are shown as blue and red traces in
Figure 3A, respectively. VsEP thresholds for CGRP (+/+) mice
ranged from −4.5 to −13.5 dB re: 1.0 g/ms and averaged
−9.0 ± 2.8 dB re: 1.0 g/ms. The threshold for CGRP (−/−)
mice ranged from −1.5 to −10.5 dB re: 1.0 g/ms with a mean
of −7.1 ± 2.8 dB re: 1.0 g/ms. On average, there was no
significant difference in VsEP thresholds between the CGRP
(+/+) and CGRP (−/−) null mice. Response amplitudes (p1–
n1), which are reflective of the population and synchrony
of primary afferents responding to the stimulus, were also
similar between CGRP (+/+) and CGRP (−/−) null animals
(Figure 3B). However, response peak latencies (p1 and n1),
reflecting activation timing of the primary afferents, were shorter
for the CGRP (−/−) null mice at all stimulus levels (Figure 3C).
MANOVA completed for data at +6 dB demonstrated that
the latency differences were significant for p1 (p = 0.004),
n1 (p = 0.014), and p2 (p = 0.006). Post hoc Tukey analysis
showed significant latency differences at all jerk levels p1
(p = 0.0028), n1 (p = 0.0009), and p2 (p = 0.0001). Yet, p1–n1
amplitude MANOVA or post hoc testing revealed no significant
differences between CGRP (−/−) null and (+/+) wildtype
controls.
We further asked whether the changes in VOR efficacy
(Luebke et al., 2014) and VsEP response latencies (this study)
might impact balance function in CGRP (−/−) mice. To evaluate
if differences in general balance performance existed between
CGRP (+/+) and CGRP (−/−) mice, we performed rotarod
testing. To test gross balance function and acclimate the mice
to the behavioral task, both CGRP (+/+) control and CGRP
(−/−) null mice were placed on a stationary rotarod and the
total time spent on the rod before falling was recorded up
to a maximum of 60 s. Both CGRP (+/+) and CGRP (−/−)
mice were able to balance on a stationary rotarod for the full
60 s (data not shown). We then performed six training runs
on a slowly accelerating rotarod. While both CGRP (+/+) and
CGRP (−/−) mice were able to learn the task (Figure 4A),
the CGRP (+/+) mice showed steeper improvement. However,
on average, the CGRP (−/−) mice were significantly impaired
relative to CGRP (+/+) controls (p = 0.003) in all three testing
trials (Figure 4B). When all three trials were averaged for CGRP
(+/+) and CGRP (−/−) mice, the control (+/+) mice were
able to stay on the rotating rotarod 6.4 s longer than (−/−)
mice.
DISCUSSION
In this study, we show that mice with a targeted deletion
of the αCGRP gene display a decrease in otolith activation
timing and balance impairments. Specifically, the loss of αCGRP
in (−/−) null mice was linked to a significant shortening of
the VsEP latency without concomitant changes in thresholds
or amplitudes. Immunohistochemistry confirmed that CGRP
was absent in the otolith organs of null (−/−) mice, while
ChAT staining appeared normal suggesting that the gross
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FIGURE 2 | CGRP is abundantly present in the neuroepithelium of CGRP (+/+) mouse otolithic organs (a) with a distribution overlapping choline acetyltransferase
(ChAT) expression (b) as illustrated in the composite image (c). (d) CGRP is absent in the neuroepithelium of CGRP (–/–) mouse otolithic organs, while choline
acetyltransferase (ChAT) expression (e) is comparable to that seen in the wildtype controls (b). (f) Composite image for CGRP (–/–) otolith showing only ChAT
staining. Staining for CGRP (green) and choline acetyltransferase-ChAT (red) with overlap indicated in yellow and orange. Arrows with letter labels indicate the
anatomical orientation of the medial (M) and anterior (A) axes of the utricular maculae. Scale bars = 10 µm.
development of EVS innervation patterns was unaltered. Lack
of changes in VsEP amplitudes and thresholds suggests that
the general sensitivity and neural synchrony of the activated
otolithic neurons are also likely unaffected in αCGRP (−/−)
animals. Taken together, the VsEP results suggest that the absence
of CGRP enhances activation timing of vestibular primary
afferents. Our findings further suggest that the change in otolith
response dynamics in αCGRP (−/−) animals, in conjunction
with a reduced VOR gain efficacy (Luebke et al., 2014), may
contribute to their impaired balance on a rotarod balance
assay.
Our findings that loss of CGRP enhances otolithic activation
timing suggest that CGRP normally slows the time for
transduction currents and/or postsynaptic transmitter release
to activate the trigger zone of primary afferents. Similar
observations in VsEPs have been reported for α9 and α10 nAChR
subunit knockout animals (Morley et al., 2017), yet in those
studies, general sensitivity of the afferents (i.e., amplitude and
threshold) was also affected by the loss of the same nAChR
subunits. Additionally, α9 nAChR subunit knockout animals are
not able to modify their VOR after a unilateral labyrinthectomy,
yet exhibit normal baseline VOR gains (Hubner et al., 2015,
2017). Interestingly, the loss of CGRP loss in the semicircular
canals results in 50% decreased VOR gain (Luebke et al.,
2014), although it is not known if the loss of CGRP impedes
VOR compensation. Given CGRP’s loss in the semicircular
canals results in decreased VOR gain (Luebke et al., 2014),
and CGRP’s loss in otoliths results in faster activation timing;
CGRP released by EVS neurons onto the vestibular end organs
may therefore serve as an activation control mechanism that
could ultimately adjust temporal and gain aspects of motor
reflexes which could result in balance impairments, as we have
observed using the modified rotarod assay (Tung et al., 2014,
2016).
However, while CGRP loss is most striking in the otolith
periphery, CGRP-dependent effects in central vestibular circuitry
may also contribute to balance impairments observed; as CGRP
is present in some vestibular nuclei cells that project to the
EVS and may likely regulate its function (Wackym et al.,
1993; Chi et al., 2007; Ahn et al., 2009). Moreover, CGRP
loss from birth may also impair upstream mechanisms that
mediate balance due to changes to the peripheral and/or
central pathways. It is also possible that CGRP-dependent
modulation influences vestibular pathways over a shorter time
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FIGURE 3 | (A) Robust duplicative VsEP waveforms were collected having two to three response peaks (p1, n1, and p2 are labeled), as shown to a 6 dB jerk
amplitude (relative to 1.0 g/ms). Waveforms at varying stimulus levels were obtained and then quantified in terms of amplitude (B) and latency (C) as a function of
jerk stimulus level. Here, CGRP (–/–) mice (red) show similar waveform morphology and peak amplitudes as CGRP (+/+) mice (blue) but have significantly prolonged
peak latencies suggesting timing differences in neural activation, ∗∗p < 0.005, ∗∗∗p < 0.001.
FIGURE 4 | (A) Example training (dashed lines) and testing trials for two 2 month (age-matched) female mice, with CGRP (–/–) null (red) and CGRP (+/+) control
(blue) mice. (B) Composite training and testing trials for all mice, with CGRP (–/–) null (red, n = 20) mice fall off rotating rotarod on average 6.4 s sooner than CGRP
(+/+) control (blue, n = 15) mice, ∗∗p < 0.005.
scale. For instance, increased CGRP levels have been linked to
migraine (Villalon and Olesen, 2009), and migraine can often
by accompanied by vertigo, dizziness, nausea, and sometimes
by abnormal caloric or vestibular-evoked myogenic potentials
(Szirmai, 1997; Furman and Marcus, 2012; Furman et al.,
2013; Lempert et al., 2013; Furman and Balaban, 2015).
While we have observed rotarod balance deficits with the
complete loss of CGRP, right/left imbalances between CGRP
signaling in migraine feedback could also contribute to migraine-
associated vertigo and balance disturbances. In fact a recent
report suggests that CGRP-induced fluctuations in afferent
responses may also contribute to the generation of motion
sickness (Xiaocheng et al., 2012). Future experiments, aimed at
understanding the effects of CGRP signaling imbalances may be
required to fully elucidate CGRP’s role in mediating vestibular
function.
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